Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort descending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort descending Location Division Business Functional Area Date Posted
(高级)医药代表 /(资深)产品专员 Eerduosi (Neimenggu Province) China International Innovative Medicines Sales Oct 17, 2024
Medical Science Liaison Neuro Ekaterinburg Russian Fed. International Innovative Medicines Research & Development Jul 25, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
Key Account Manager, Haematology - South West Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Aug 21, 2024
Medical Science Liaison Immunology Field Force (England / Wales) United Kingdom International Innovative Medicines Research & Development Oct 10, 2024
KAM/Senior KAM - Oncology - North London Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 20, 2024
Key Account Manager , Haematology - Yorkshire, East Midlands, Northamptonshire. Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 03, 2024
Clinical Research Associate Field Force (Italy) Italy Development Innovative Medicines Research & Development Oct 16, 2024
Embrace Advisor Verona Field Force (Italy) Italy International Innovative Medicines Others Oct 16, 2024
Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) Field Force (Scotland) United Kingdom International Innovative Medicines Sales Sep 27, 2024
Medical Science Liaison - Breast Cancer Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
Medical Science Liaison - Rheumatology - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
Liaison en sciences médicales - Cancer du sein Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 23, 2024
Liaison en sciences médicales - Rheumatologie - Ontario Field Non-Sales (Canada) Canada International Innovative Medicines Research & Development Oct 25, 2024
MSL Tumeurs Solides - Nord Est Field Non-Sales (France) France International Innovative Medicines Research & Development Apr 29, 2024
Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Jul 19, 2024
Medical Science Liaison Allergy / Derm MN, WI, ND, SD Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Apr 25, 2024
Senior Clinical Research Associate, Western Region Field Non-Sales (USA) USA Development Innovative Medicines Research & Development May 03, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 16, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 17, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 17, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 09, 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales Oct 17, 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales Oct 17, 2024
Senior Clinical Research Associate (Remote) Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Oct 17, 2024
Allergy-Territory Account Specialist – Seattle E, WA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 11, 2024
Neuroscience Territory Account Specialist – Denver - Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 12, 2024
Rheumatology Territory Account Specialist – Denver Metro - Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 14, 2024
Oncology Specialist - RLT- Portland- Remote Field Sales (USA) USA US Innovative Medicines Sales Apr 29, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines Sales Apr 30, 2024
Neuroscience-Territory Account Specialist – San Jose, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 01, 2024
Allergy-Territory Account Specialist – Green Bay, WI – Remote Field Sales (USA) USA US Innovative Medicines Sales Aug 27, 2024
Dermatology Territory Account Specialist – Boston South – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 10, 2024
Dermatology Territory Account Specialist – Portland ME – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 10, 2024
Rheumatology Territory Account Specialist – Houston West – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 10, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 23, 2024
Allergy-Territory Account Specialist – Wichita, KS – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia